Hinge Health’s James Pursley plans 50,000-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
James Pursley, an officer of Hinge Health, Inc., reported a planned sale of 50,000 common shares, with an aggregate market value of $5,405,000.00 and an approximate sale date of November 20, 2026. His earlier Rule 10b5-1 sales were 33,000 shares on August 21, 2026, for gross proceeds of $2,905,663.20, and 33,000 shares on September 21, 2026, for $3,106,504.50.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units technical
Performance Stock Units technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent Hinge Health (HNGE) sales did James Pursley report?
What date is listed for James Pursley's HNGE Rule 10b5-1 plan or instruction?
AI-generated analysis. How Rhea-AI works. Not financial advice.